A top vaccine advisor at the FDA was forced to resign on Friday. In his resignation letter, Dr. Peter Marks, wrote "truth and ...

A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...

Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

Dr. Nisha Acharya got a letter from the National Institutes of Health terminating her grant to study the safety and ...

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...

Before joining Moderna, Cronin spent close to 20 years at Ogilvy, working within its global healthcare department in ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...